CEO
Haim Neerman
Haim’s career spans over 20 years of technology entrepreneurship. Prior to co-founding Variantyx, Haim co-founded Credorax Inc. – a global...
- Our Tests
- Rare Genetic Disorders
- Neurology Analyses
- Genomic Unity® 2.0
- Whole Genome Analysis
- Exome Plus Analysis
- Exome Analysis
- CNV Analyses
- Targeted Analyses
- Ataxia Repeat Expansion Analysis
- Comprehensive Ataxia Analysis
- Dementia Analysis
- Epilepsy Analysis
- Motor Neuron Disorders Analysis
- Movement Disorders Analysis
- Muscular Dystrophy Analysis
- DMD Analysis
- Neuromuscular Disorders Analysis
- Neuropathies Analysis
- X-linked Intellectual Disability Plus Analysis
- Rapid Genome
- Reproductive Genetics
- Precision Oncology
- Custom Analysis
- Wellness
- Rare Genetic Disorders
- Patients
- Providers
- Resources
- Company